Oncology Therapeutic
Sep 17, 2008 at 15:11 | Source: CNBC-TV18
Mar 14, 2008 at 16:50
Feb 26, 2008 at 14:36
Nov 19, 2007 at 10:41 | Source: Moneycontrol.com
Apr 12, 2007 at 16:12
Related News »
Similarly differentiated dynamics have been identified in the annual costs of therapy in these therapeutic markets. Scope - Data and analysis on the orphan diseases therapeutics in oncology market in the leading geographies of the world - the US ...
May 22, 2012 at 13:08 | Source: PRLog (free press release)
About ZIOPHARM Oncology, Inc.: ZIOPHARM Oncology is a biopharmaceutical ... the Company is developing an oral capsule form of palifosfamide. IL-12 DNA, a novel DNA therapeutic that is delivered to the patient's tumor and expresses interleukin ...
May 25, 2012 at 16:46 | Source: Yahoo Finance
He is a member of several scientific and medical societies, including the American Society of Therapeutic Radiology and Oncology, and has lectured and published many research papers on his branch of medicine. Rosenbluth is a graduate of Harvard Medical ...
May 24, 2012 at 05:28 | Source: NorthJersey.com
Similarly differentiated dynamics have been identified in the annual costs of therapy in these therapeutic markets. Scope - Data and analysis on the orphan diseases therapeutics in oncology market in the leading geographies of the world – the US ...
May 16, 2012 at 03:43 | Source: SBWire
Annualized market data for the orphan diseases therapeutics in oncology market from 2004 to 2010, with forecasts to 2018. - Market data on the geographical landscape and therapeutic landscape, including market size, annual cost of therapy, sales volume and ...
May 17, 2012 at 10:37 | Source: CNBC
In oncology, the company's lead program is PROSTVACR , a therapeutic vaccine candidate for advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 trial and is being developed under a collaboration agreement with the National ...
May 18, 2012 at 05:42 | Source: Reuters
For further study details, please visit www.clinicaltrials.gov. “With the initiation of this trial, we now have three targeted oncology therapeutic candidates in clinical development, all of which use distinct and novel mechanisms of action to ...
May 26, 2012 at 11:09 | Source: Yahoo Finance
“With the initiation of this trial, we now have three targeted oncology therapeutic candidates in clinical development, all of which use distinct and novel mechanisms of action to fight cancer,” said William Slichenmyer, M.D., Sc.M., chief medical officer at Aveo.
May 25, 2012 at 06:59 | Source: pharmabiz.com
The Eastern Cooperative Oncology Group (ECOG) Research and Education Foundation ... with an integrated focus on therapeutic, diagnostic, preventative, and biomarker-driven trials. See http://www.ecog-acrin.org.
May 23, 2012 at 13:00 | Source: YAHOO!
Hait, M.D., Ph.D., Global Head, Janssen R&D and Head, Oncology Therapeutic Area. "These data presentations demonstrate our ongoing commitment to furthering the understanding of our compounds in a number of hematology and oncology settings." The following ...
May 18, 2012 at 13:34 | Source: PR Newswire